EMA-话题@MedSci

#EMA#

580篇内容 | 2460人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1317393, encodeId=b25f131e393c7, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Pediatr Hematol Oncol：儿童颅脑肿瘤接受颅内放射治疗诱发白内障, objectType=article, longId=135578, objectId=e7b21355e841, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7b21355e841, replyNumber=0, likeNumber=83, createdTime=2018-04-18, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7b21355e841, moduleTitle=J Pediatr Hematol Oncol：儿童颅脑肿瘤接受颅内放射治疗诱发白内障, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7b21355e841)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317392, encodeId=4137131e392a1, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：Q热或与非霍奇金淋巴瘤的发病率无相关性, objectType=article, longId=134763, objectId=e838134e63c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e838134e63c4, replyNumber=0, likeNumber=70, createdTime=2018-04-12, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e838134e63c4, moduleTitle=Lancet haemat：Q热或与非霍奇金淋巴瘤的发病率无相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e838134e63c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317391, encodeId=278e131e391d9, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：铁过负荷可影响急性髓系白血病和骨髓增生异常综合征患者进行异体造血干细胞移植后的预后, objectType=article, longId=134407, objectId=1f4713440e66, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f4713440e66, replyNumber=0, likeNumber=15, createdTime=2018-04-08, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f4713440e66, moduleTitle=Lancet haemat：铁过负荷可影响急性髓系白血病和骨髓增生异常综合征患者进行异体造血干细胞移植后的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f4713440e66)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317390, encodeId=2e0b131e39045, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=EMA审查赛诺菲的I型糖尿病药物sotagliflozi, objectType=article, longId=133910, objectId=109c13391068, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=109c13391068, replyNumber=0, likeNumber=56, createdTime=2018-04-01, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=109c13391068, moduleTitle=EMA审查赛诺菲的I型糖尿病药物sotagliflozi, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=109c13391068)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317389, encodeId=e1d2131e389b6, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：BP1001，Grb2的反义寡核苷酸，用于难治性/复发性恶性血液病的疗效和安全性评估, objectType=article, longId=132551, objectId=bc0a132551d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc0a132551d5, replyNumber=0, likeNumber=12, createdTime=2018-03-17, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc0a132551d5, moduleTitle=Lancet haemat：BP1001，Grb2的反义寡核苷酸，用于难治性/复发性恶性血液病的疗效和安全性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc0a132551d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317388, encodeId=f94a131e388b0, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：Voxtalisib（XL765）用于滤泡性淋巴瘤患者可获得良好的治疗效果, objectType=article, longId=132542, objectId=4f8e13254254, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f8e13254254, replyNumber=0, likeNumber=57, createdTime=2018-03-17, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f8e13254254, moduleTitle=Lancet haemat：Voxtalisib（XL765）用于滤泡性淋巴瘤患者可获得良好的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f8e13254254)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317387, encodeId=6faf131e38777, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Hematol Oncol：调控造血发育与白血病发生新机制, objectType=article, longId=132141, objectId=af34132141e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af34132141e8, replyNumber=0, likeNumber=64, createdTime=2018-03-13, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af34132141e8, moduleTitle=J Hematol Oncol：调控造血发育与白血病发生新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af34132141e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317386, encodeId=148b131e3865d, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=色视症的基因治疗药物获EMA的优先资格, objectType=article, longId=131472, objectId=5cef1314e28d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5cef1314e28d, replyNumber=0, likeNumber=73, createdTime=2018-03-06, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5cef1314e28d, moduleTitle=色视症的基因治疗药物获EMA的优先资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5cef1314e28d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317385, encodeId=e226131e385ee, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：血液恶性肿瘤患者临床结局：PICCs vs cCVCs, objectType=article, longId=131258, objectId=358813125838, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=358813125838, replyNumber=0, likeNumber=73, createdTime=2018-03-04, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=358813125838, moduleTitle=Am J Hematol：血液恶性肿瘤患者临床结局：PICCs vs cCVCs, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=358813125838)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317384, encodeId=7a1c131e384a5, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Biomed Res Int：Semaphorin3A/Neuropilin-1信号轴在根尖牙周炎中的表达降低, objectType=article, longId=131168, objectId=2103131168f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2103131168f4, replyNumber=0, likeNumber=51, createdTime=2018-03-03, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2103131168f4, moduleTitle=Biomed Res Int：Semaphorin3A/Neuropilin-1信号轴在根尖牙周炎中的表达降低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2103131168f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317383, encodeId=df44131e3838f, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Br J Haematol：利妥昔单抗诱导治疗无症状滤泡性淋巴瘤省钱又有效？, objectType=article, longId=130821, objectId=fe7113082182, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe7113082182, replyNumber=0, likeNumber=43, createdTime=2018-03-01, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe7113082182, moduleTitle=Br J Haematol：利妥昔单抗诱导治疗无症状滤泡性淋巴瘤省钱又有效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe7113082182)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317382, encodeId=1ca3131e382b0, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Br J Haematol：DA-EPOCH-R能否作为原发性纵膈B细胞淋巴瘤患者的治疗方案？, objectType=article, longId=130819, objectId=73341308194e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73341308194e, replyNumber=0, likeNumber=18, createdTime=2018-03-01, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73341308194e, moduleTitle=Br J Haematol：DA-EPOCH-R能否作为原发性纵膈B细胞淋巴瘤患者的治疗方案？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73341308194e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317381, encodeId=41f7131e3813c, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：剂量调整的EPOCH化疗能改善外周T细胞淋巴瘤患者结局？, objectType=article, longId=130749, objectId=b8ba130e490e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8ba130e490e, replyNumber=0, likeNumber=47, createdTime=2018-02-28, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8ba130e490e, moduleTitle=Haematologica：剂量调整的EPOCH化疗能改善外周T细胞淋巴瘤患者结局？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8ba130e490e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317380, encodeId=7b60131e380a1, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Hematol Oncol：难治性/复发性MCL患者：来那度胺是良药吗？, objectType=article, longId=130439, objectId=5dcb130439ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5dcb130439ce, replyNumber=0, likeNumber=64, createdTime=2018-02-25, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5dcb130439ce, moduleTitle=J Hematol Oncol：难治性/复发性MCL患者：来那度胺是良药吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5dcb130439ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317379, encodeId=b01d131e3792e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematol：改善CLL老年患者生存期：利妥昔单抗维持治疗 vs 观察治疗, objectType=article, longId=130401, objectId=0ffc13040150, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ffc13040150, replyNumber=0, likeNumber=73, createdTime=2018-02-25, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ffc13040150, moduleTitle=Lancet Haematol：改善CLL老年患者生存期：利妥昔单抗维持治疗 vs 观察治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ffc13040150)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317378, encodeId=c1d5131e37809, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=EMA接受了Romosozumab治疗骨质疏松症的上市授权申请, objectType=article, longId=128300, objectId=0d7d12830097, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d7d12830097, replyNumber=0, likeNumber=60, createdTime=2018-02-01, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d7d12830097, moduleTitle=EMA接受了Romosozumab治疗骨质疏松症的上市授权申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d7d12830097)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317377, encodeId=763a131e377b7, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：用罗米司亭治疗血小板减少的低风险的骨髓增生异常综合征，进展成急性髓系白血病的风险追踪, objectType=article, longId=127999, objectId=036712e999a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=036712e999a7, replyNumber=0, likeNumber=16, createdTime=2018-01-29, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=036712e999a7, moduleTitle=Lancet haemat：用罗米司亭治疗血小板减少的低风险的骨髓增生异常综合征，进展成急性髓系白血病的风险追踪, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=036712e999a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317376, encodeId=0f47131e3767e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：R-CHOP、放疗、利妥昔单抗维持的序贯疗法治疗晚期滤泡性淋巴瘤的效果和安全性, objectType=article, longId=127695, objectId=d57d12e6952c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d57d12e6952c, replyNumber=0, likeNumber=54, createdTime=2018-01-27, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d57d12e6952c, moduleTitle=Lancet haemat：R-CHOP、放疗、利妥昔单抗维持的序贯疗法治疗晚期滤泡性淋巴瘤的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d57d12e6952c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317375, encodeId=e4e0131e375b2, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematology:血液学恶性肿瘤患者的经典抗菌疗法该何时停止？, objectType=article, longId=126979, objectId=2b9c1269e95a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b9c1269e95a, replyNumber=0, likeNumber=87, createdTime=2018-01-21, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b9c1269e95a, moduleTitle=Lancet Haematology:血液学恶性肿瘤患者的经典抗菌疗法该何时停止？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b9c1269e95a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317374, encodeId=ceba131e37425, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Mediterr J Hematol Infect Dis：Burkina Faso（非洲一国家）的隐匿性HBV感染的流行率和相关基因型, objectType=article, longId=126617, objectId=2c7412661ee8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c7412661ee8, replyNumber=0, likeNumber=84, createdTime=2018-01-17, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c7412661ee8, moduleTitle=Mediterr J Hematol Infect Dis：Burkina Faso（非洲一国家）的隐匿性HBV感染的流行率和相关基因型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c7412661ee8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EMA

2020-05-29

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

J Pediatr Hematol Oncol：儿童颅脑肿瘤接受颅内放射治疗诱发白内障

2018-04-18

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：Q热或与非霍奇金淋巴瘤的发病率无相关性

2018-04-12

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：铁过负荷可影响急性髓系白血病和骨髓增生异常综合征患者进行异体造血干细胞移植后的预后

2018-04-08

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

EMA审查赛诺菲的I型糖尿病药物sotagliflozi

2018-04-01

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：BP1001，Grb2的反义寡核苷酸，用于难治性/复发性恶性血液病的疗效和安全性评估

2018-03-17

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：Voxtalisib（XL765）用于滤泡性淋巴瘤患者可获得良好的治疗效果

2018-03-17

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

J Hematol Oncol：调控造血发育与白血病发生新机制

2018-03-13

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

色视症的基因治疗药物获EMA的优先资格

2018-03-06

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：血液恶性肿瘤患者临床结局：PICCs vs cCVCs

2018-03-04

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Biomed Res Int：Semaphorin3A/Neuropilin-1信号轴在根尖牙周炎中的表达降低

2018-03-03

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Br J Haematol：利妥昔单抗诱导治疗无症状滤泡性淋巴瘤省钱又有效？

2018-03-01

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Br J Haematol：DA-EPOCH-R能否作为原发性纵膈B细胞淋巴瘤患者的治疗方案？

2018-03-01

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：剂量调整的EPOCH化疗能改善外周T细胞淋巴瘤患者结局？

2018-02-28

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

J Hematol Oncol：难治性/复发性MCL患者：来那度胺是良药吗？

2018-02-25

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematol：改善CLL老年患者生存期：利妥昔单抗维持治疗 vs 观察治疗

2018-02-25

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

EMA接受了Romosozumab治疗骨质疏松症的上市授权申请

2018-02-01

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：用罗米司亭治疗血小板减少的低风险的骨髓增生异常综合征，进展成急性髓系白血病的风险追踪

2018-01-29

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：R-CHOP、放疗、利妥昔单抗维持的序贯疗法治疗晚期滤泡性淋巴瘤的效果和安全性

2018-01-27

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematology:血液学恶性肿瘤患者的经典抗菌疗法该何时停止？

2018-01-21

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Mediterr J Hematol Infect Dis：Burkina Faso（非洲一国家）的隐匿性HBV感染的流行率和相关基因型

2018-01-17

科室
- - 订阅+
  - 更多科室
工具
服务